BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
EXCLUSIVE: DelMar Pharmaceuticals CEO Outlines 2015 Plans, Looks to Clinical Cancer Trials     2/27/2015
Rigel Lands $339 Million+ Cancer Deal With Bristol-Myers Squibb     2/24/2015
Express Scripts Inc. Cheers As Data Shows Drug Pricing Up 3-Fold, Even When Adjusted For Inflation, Survival     2/5/2015
EXCLUSIVE: Eli Lilly Exec Tells BioSpace New Cancer Tool Could Be "Historic"     1/30/2015
Curis, Inc., Aurigene Discovery Technologies Limited Forge $415 Million+ Immuno-Oncology Pact     1/22/2015
Pfizer Plots Path Outside of Melanoma in Bid to Join Cancer Race     1/19/2015
Pfizer's New Type of Cancer Drug May Get Early Approval: Analysts     1/14/2015
J.P. Morgan: Express Scripts Inc. CEO Said it Will Take On Cancer Drug Pricing Next     1/13/2015
U.K. Cancer Drugs Fund Delists Big Pharmas' Meds; Novartis AG Slams Process     1/12/2015
Incyte Corporation, Agenus Strike $410 Million+ Immuno-Oncology Antibodies Pact     1/9/2015
Oncothyreon Inc. Strikes $300 Million Cancer Pact With Array BioPharma, Inc.     12/15/2014
Bayer AG Loses Battle To Block Generic Cancer Drug In India's Top Court     12/15/2014
Pfizer Grabs Rights To Preclinical Drugs From Startup In $29 Million+ Deal     12/9/2014
Evgen Pharma Will Float £20M IPO To Fund Cancer Drug Trials     12/4/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
 Featured Stories
Olive Oil Compound Kills Cancer In Minutes, Rutgers University Reveals     2/24/2015
Flame Retardants Used In Couches May Cause Metabolic, Liver Problems, University of New Hampshire Reveals     2/23/2015
Popular Soda Ingredient Poses Cancer Risk To Consumers, Johns Hopkins University Reveals     2/20/2015
Go Green: 6 Surprising Health Benefits Of Green Tea     2/20/2015
A New Weapon In The Fight Against Cancer, Concordia University Reveals     2/20/2015
Drinking Coffee May Lower Endometrial Cancer Risk, Imperial College London Study     2/9/2015
"Half Of UK People" Will Get Cancer     2/4/2015
How Drinking Green Tea Can Kill Cancer Cells, Penn State University Study     2/4/2015
Schoolgirl Comment Points To Antibiotics As New Cancer Treatments, University of Manchester Study     1/29/2015
Broccoli Compound May Treat Prostate Cancer, Texas A&M Health Science Center Study     1/22/2015
Sitting Too Much? Even Exercise May Not Save You, University Health Network Study     1/21/2015
How Vitamin D May Fight Colorectal Cancer, Dana-Farber Cancer Institute Study     1/16/2015
Unhealthy Insulin Levels May Boost Breast Cancer Risk, Imperial College London Study     1/16/2015
Stroke Risk Spikes After New Cancer Diagnoses, Weill Cornell Medical College Study     1/9/2015
Most Cancer Are Caused By Bad Luck, Johns Hopkins Kimmel Cancer Center Study Shows     1/5/2015
 More News
Almac Discovery Initiates Phase 1 Study Of ALM201 For The Treatment Of Patients With Advanced Ovarian Cancer And Other Solid Tumours     3/2/2015
Kite Pharma (KITE) Expands Its Research And Development Collaboration With The National Cancer Institute To Develop A Next Generation Of Cancer Immunotherapy Products For Solid Tumors     3/2/2015
European Medicines Agency Release: Novartis AG (NVS)'s Zykadia Recommended For Approval In Advanced Non Small Cell Lung Cancer     2/27/2015
Agilent Technologies Inc. (A) Introduces Two Innovative Products To Advance Clinical Cancer Research     2/26/2015
Caris Life Sciences' Multiplatform Tumor Profiling Helps To Identify Potential Predictive Biomarkers In Renal Cell Carcinoma     2/26/2015
Nodality, Inc. Presents Data From Immuno-Oncology Program Applying Company’s Novel Single Cell Network Profiling (SCNP) Platform     2/25/2015
CryoPort, Inc. Provides Logistics Solution And Services For Kite Pharma (KITE)'s Lead Clinical Program In Cancer Immunotherapy     2/24/2015
Progenics Pharmaceuticals, Inc. (PGNX) To Present Full Phase 2 Data For PSMA ADC At The 2015 American Society of Clinical Oncology GU Symposium     2/24/2015
NovoCure Ltd. Enrolls The First Patient In Its Phase II STELLAR Trial Of Tumor Treating Fields Together With Pemetrexed And Cisplatin Or Carboplatin For The Treatment Of Malignant Mesothelioma     2/23/2015
NYU Langone Medical Center, Technion-Israel Institute Of Technology To Forge Groundbreaking Partnership In Cancer Research     2/18/2015
VBL Therapeutics (VBLX) Announces Removal Of FDA Partial Clinical Hold On VB-111     2/17/2015
Week in Review: Cellular Biomedicine Group (CBMG) In-Licenses Cancer Immunotherapy From China     2/16/2015
Iomet Pharma Demonstrates Superior In Vivo PK/PD Properties In Pre-Clinical IDO, TDO And Dual IDO/TDO Cancer Immunotherapy Programs     2/11/2015
Biothera Immunotherapy Binds To Multiple Immune Cell Receptors To Kill Cancer     2/10/2015
Galena Biopharma  (GALE) Enrolls 700th Patient In Neuvax (Nelipepimut-S) Phase 3 PRESENT Clinical Trial     2/9/2015